SCHEMBL5658420

SCHEMBL5658420

Cc1cc(C)cc(C2(c3cc(C)c(O)c(C)c3)C(=O)N(Cc3ccccc3)c3ccccc32)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
TP53 P04637 3/20 0.49
ALDH1A1 P00352 7/20 0.47
CNR1 P21554 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
HSD17B10 Q99714 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPSR1 Q6W5P4 3/20 0.45
SCN9A Q15858 2/20 0.45
USP2 O75604 1/20 0.44
MAPK1 P28482 1/20 0.44
P2RX1 P51575 1/20 0.43
P2RX3 P56373 1/20 0.43
P2RX4 Q99571 1/20 0.43
P2RX7 Q99572 1/20 0.43
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CRHBP P24387 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659203 0.93 CNR1 (0.52) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL5660616 0.90 CNR1 (0.61) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL14457619 0.89 CNR1 (0.47) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL5659155 0.87 MAPT (0.50) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL14457581 0.86 SCN9A (0.51) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL5659599 0.84 SCN9A (0.58) MAPTTP53CNR1GPR55SMN1; SMN2
SCHEMBL5659213 0.84 CNR1 (0.46) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL5658501 0.84 CNR1 (0.52) MAPTTP53ALDH1A1CNR1GPR55
SCHEMBL5660202 0.83 TP53 (0.54) MAPTTP53ALDH1A1CNR1HSD17B10
SCHEMBL5659386 0.83 GFER (0.52) MAPTTP53ALDH1A1CNR1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 MAPT 3588/4885TP53 3370/4885ALDH1A1 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.